Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_assertion description "[The SRC-ABL inhibitor bosutinib is one of the five tyrosine kinase inhibitors currently approved for the treatment of Philadelphia chromosome-positive leukemias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_assertion evidence source_evidence_literature NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_assertion SIO_000772 24490604 NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_assertion wasDerivedFrom befree-2016 NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_assertion wasGeneratedBy ECO_0000203 NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1151555.RAMm8SZ5ecqqG43QjcCgq8UBVcKlSMllW8_ytU3WZHbZE130_provenance.